Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to ...

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and ...

Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke, but a new study suggests those ...

Despite ongoing debate, medications such as Ozempic continue to rank among the most commonly prescribed treatments for weight ...

March 20 () - Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis ...

Lab-made drugs soaked into the pages of letters, books and even legal documents are being smuggled behind bars, killing inmates and frustrating investigators.

Taking GLP-1 drugs for diabetes has been shown to lower the risk of ​adverse heart events, but a new analysis found that going off the medication – even for a few months – may increase the ‌odds of ...

Some less common but serious side effects of gabapentin include suicidal thoughts, allergic reactions, and serious breathing ...

Scientists have discovered a compound in python blood that reduces appetite and could lead to safer, more effective weight-loss drugs.

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their ...

How the rush to release affordable and accessible versions of weight loss drugs could reshape the fight against ‘diabesity’ ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.